|
26
|
Re C, Belladelli F, Cei F, Nazario T, Basile G, Musso G, Fallara G, Rosiello G, Matloob R, Moschini M, Cignoli D, Canibus D, Karakiewicz P, Rowe I, Lucianò R, Doglioni C, Colecchia M, Bertini R, Briganti A, Montorsi F, Salonia A, Larcher A, Capitanio U. Lymphovascular invasion predicts lymph node involvement in patients with renal cell carcinoma. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00504-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
27
|
Brembilla G, Gandaglia G, Stabile A, Mazzone E, Sorce G, Pellegrino F, Robesti D, Pellegrino A, Longoni M, Scilipoti P, Quarta L, Zaurito P, Di Gaeta E, Lavalle S, Cosenza M, Montorsi F, Briganti A, Esposito A, De Cobelli F. Impact of Prostate Imaging Quality (PI-QUAL) score on the detection of clinically significant prostate cancer in men undergoing MRI-targeted biopsy. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01012-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
28
|
Ratti M, Gandaglia G, Armando S, Mazzone E, Scuderi S, Barletta F, Mottet N, Williamson P, Moss C, Beyer K, Muhammad Imran O, Maclennan S, Zong J, Cornford P, Maclennan S, Aiyegbusi O, Van Hemelrijck M, Alleva E, Derevianko A, Sisca E, N’dow J, Francesco M, Briganti A. A systematic review to evaluate Patient-Reported Outcomes Measures (PROMs) for metastatic prostate cancer according to the COSMIN methodology – A PIONEER wp2 project. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01038-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
29
|
Piccinelli M, Panunzio A, Tappero S, Barletta F, Incesu RB, Luzzago S, Mistretta F, Nardini S, Tozzi M, Cozzi G, Bottero D, Ferro M, Tian Z, Saad F, Shariat S, Graefen M, Briganti A, Chun F, Terrone C, Antonelli A, De Cobelli O, Musi G, Karakiewicz P. Cancer-specific mortality free survival rates in non-metastatic non-clear cell renal carcinoma patients at intermediate/high risk of recurrence. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00506-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
30
|
Robesti D, Tenace N, Re C, Leni R, De Angelis M, Gandaglia G, Mazzone E, Stabile A, Fossati N, Gallina A, Doglioni C, Colecchia M, Montorsi F, Briganti A, Moschini M, Lucianò R. Assessing the impact of TURBT specimens review by a dedicated uropathologist on clinical decision making process: Results from a single tertiary referral center. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01097-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
31
|
Mazzone E, Gandaglia G, Stabile A, Robesti D, Necchi A, Cirulli G, Pellegrino A, Scuderi S, Raggi D, Marandino L, Barletta F, De Angelis M, Cucchiara V, Rosiello G, Sorce G, Pellegrino F, Longoni M, Scilipoti P, Fossati N, Montorsi F, Briganti A. Tailoring the optimal use of androgen-deprivation therapy concomitant to post-operative radiotherapy among men with pN1 prostate cancer. Long-term results of a large, single Institution series. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01153-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
32
|
Mazzone E, Gandaglia G, Stabile A, Cucchiara V, Rosiello G, Sorce G, Pellegrino F, Scuderi S, Barletta F, Robesti D, Leni R, De Angelis M, Pellegrino A, Longoni M, Scilipoti P, Brembilla G, De Cobelli F, Samanes Gajate A, Picchio M, Gianolli L, Van Leeuwen F, Van Oosterom M, Montorsi F, Briganti A. Defining the optimal target-to-background count rate to identify positive lymph nodes in patients undergoing robot-assisted 99mtc-PSMA-radioguided surgery for prostate cancer: A per-region analysis of a prospective, phase II study. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00694-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
33
|
Marra G, Rajwa P, Montefusco G, Van Den Bergh R, Zattoni F, Dal Moro F, Magli A, Affentranger A, Grogg J, Hermanns T, Malkiewicz B, Kowalczyk K, Shariat S, Bianchi A, Antonelli A, Gallina S, Berchiche W, Cathelineau X, Afferi L, Fankhauser C, Mattei A, Scuderi S, Briganti A, Gontero P, Gandaglia G. Impact of pre-operative PSMA PET/CT for men with cN0M0 conventional imaging and pN+ prostate cancer: Results from a multicenter study. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00296-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
34
|
Gandaglia G, Robesti D, Bianchi L, Schiavina R, Brunocilla E, Afferi L, Mattei A, Zattoni F, Rajwa P, Shariat S, Kesch C, Sierra J, Gontero P, Marra G, Guo H, Gomez Rivas J, Zhuang J, Amparore D, Dal Moro F, Porpiglia F, Darr C, Fendler W, Picchio M, Montorsi F, Briganti A. Can we rely on available models to identify candidates for extended Pelvic Lymph Node Dissection (ePLND) in men staged with PSMA-PET? External validation of the Briganti nomograms and development of a novel tool to identify optimal candidates for ePLND. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00699-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
35
|
Barletta F, Mazzone E, Gandaglia G, Bianchi L, Schiavina R, Afferi L, Mattei A, Zanotti F, Reitano G, Rajwa P, Shariat S, Kesch C, Ibanez L, Gomez-Rivas J, Marra G, Guo H, Zhuang J, Amparore D, Cisero E, Porpiglia F, Picchio M, Checcucci E, Huebner N, Montorsi F, Briganti A. Which men with cN1 prostate cancer at PSMA PET/CT represent the ideal candidate for radical prostatectomy? Development of a novel risk stratification tool for individualized approaches based on a large, multi-institutional series. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00705-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
36
|
Pellegrino F, Stabile A, Gandaglia G, Cucchiara V, Mazzone E, Leni R, Sorce G, Scuderi S, Barletta F, Robesti D, Pellegrino A, De Angelis M, Quarta L, Zaurito P, Brembilla G, Zaffuto E, Esposito A, De Cobelli F, Montorsi F, Briganti A. Impact of radiologist expertise on PI-RADS distribution and detection of clinically significant prostate cancer: Results from a single, high volume center. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01023-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
37
|
Stabile A, Leni R, Gandaglia G, Mazzone E, Cucchiara V, Pellegrino F, Rosiello G, Nocera L, Cirulli G, Robesti D, Cannoletta D, Longoni M, Scilipoti P, De Angelis M, Pellegrino A, Larcher A, Capitanio U, Montorsi F, Briganti A. A patient tailored follow-up protocol for men with prostate cancer managed with active surveillance with the use of multiparametric magnetic resonance imaging: Identifying predictors of early and late reclassification in a large single institution cohort. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00994-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
38
|
Bandini M, Lucianò R, Giannese F, Scotti G, Oneto C, Barletta F, Cirulli G, Cucchiara V, Stabile A, Mazzone E, Sorce G, Tenace N, Scarfò F, Brembilla G, Esposito A, Morelli M, Lazarevic D, De Cobelli F, Doglioni C, Gandaglia G, Tonon G, Montorsi F, Briganti A. A novel model Integrating clinical, mp-MRI, and epigenomic features to predict lymph node invasion in prostate cancer patients undergoing radical prostatectomy and pelvic lymph node dissection. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00124-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
39
|
Baiamonte G, Rosiello G, Cei F, Tenace N, Musso G, Basile G, Re C, Fallara G, Belladelli F, Cignoli D, Colecchia M, Rowe I, De Cobelli F, Pennella R, Della Corte A, Brembilla G, Bertini R, Briganti A, Necchi A, Montorsi F, Salonia A, Larcher A, Lucianò R, Capitanio U. The current role of renal tumor biopsy in the management of small renal masses: Long-term results from a prospective, single-institutional database. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01315-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
40
|
Rosiello G, Baiamonte G, Basile G, Fallara G, Re C, Musso G, Cei F, Cignoli D, Avesani G, Disabato N, Villa G, Boarin M, Canibus D, Karakiewicz P, Dehò F, Suardi N, Briganti A, Salonia A, Montorsi F, Larcher A, Capitanio U. Lawton instrumental activities of daily living scale identifies patients at high-risk of adverse outcomes after kidney surgery for renal cancer: A prospective clinical study. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00897-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
41
|
Cano Garcia C, Flammia R, Piccinelli M, Panunzio A, Tappero S, Barletta F, Incesu RB, Law K, Tian Z, Saad F, Kapoor A, Shariat S, Tilki D, Briganti A, Terrone C, Antonelli A, De Cobelli O, Hoeh B, Kluth L, Chun F, Karakiewicz P. Differences in survival of clear cell metastatic renal cell carcinoma patients according to partial vs. radical nephrectomy. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00377-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
42
|
Scuderi S, Gandaglia G, Mazzone E, Huebner N, Brunocilla E, Dal Moro F, Sartorello A, Ibanez L, Jesús MS, Mattei A, Afferi L, Shariat S, Wolfgang F, Picchio M, Marra G, Zattoni F, Reitano G, Rajwa P, Gomez-Rivas J, Kesch C, Porpiglia F, Amparore D, Checcucci E, Montorsi F, Briganti A. The prognostic impact of preoperative psma-pet on early oncological outcomes in prostate cancer patients treated with radical prostatectomy: Results of a multi-center analysis. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00297-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
43
|
Cei F, Rosiello G, Basile G, Fallara G, Re C, Musso G, Belladelli F, Pennella R, Guazzarotti G, Brembilla G, Damascelli A, Cristel G, Della Corte A, De Cobelli F, Matloob R, Bertini R, Briganti A, Salonia A, Karakiewicz P, Mottrie A, Montorsi F, Capitanio U, Larcher A. Pre-operative risk calculator for the probability of completing surgery for kidney cancer: The key role of tumour complexity and surgical experience. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00887-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
44
|
Fallara G, Martini A, Rosiello G, Belladelli F, Musso G, Cei F, Basile G, Re C, Cignoli D, De Cobelli F, Brembilla G, Marandino L, Raggi D, Gandaglia G, Mazzone E, Moschini M, Stabile A, Briganti A, Necchi A, Montorsi F, Salonia A, Larcher A, Capitanio U. Defining the most useful intermediate endpoint for overall survival in intermediate and high-risk clear cell carcinoma. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00517-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
45
|
Robesti D, Mazzone E, Gandaglia G, Stabile A, Necchi A, Raggi D, Marandino L, Cirulli G, Scuderi S, Barletta F, De Angelis M, Balestrazzi E, Fanti S, Cucchiara V, Farolfi A, Bianchi L, Schiavina R, Montorsi F, Briganti A. The prognostic role of 68Ga-PSMA PET/CT and the impact of metastasis-directed therapy on cancer progression in men with biochemical recurrence from prostate cancer. Results from a large, single Institution series. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01159-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
46
|
Ghezzo S, Brembilla G, Russo T, Gotuzzo I, Preza E, Samanes Gajate A, Mapelli P, Bezzi C, Cucchiara V, Mongardi S, Neri I, Gandaglia G, Montorsi F, Briganti A, De Cobelli F, Gianolli L, Scifo P, Picchio M. 68Ga-PSMA PET radiomics for the prediction of post-surgical ISUP grade in primary prostate cancer patients. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01024-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
47
|
Belladelli F, Re C, Cei F, Musso G, Fallara G, Basile G, Rosiello G, Cignoli D, Canibus D, Bertini A, Bertini R, Lucianò R, Tenace N, Necchi A, Raggi D, Marandino L, Montorsi F, Salonia A, Briganti A, Guazzarotti G, Brembilla G, De Cobelli F, Capitanio U, Larcher A. Clinical benefit and cost-effectiveness of a biopsy-all strategy in patients diagnosed with renal mass: Simulation of a randomized controlled trial. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01314-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
48
|
Chierigo F, Tappero S, Panunzio A, Cano Garcia C, Barletta F, Piccinelli M, Incesu RB, Parodi S, Dell’Oglio P, Antonelli A, Graefen M, Chun F, Briganti A, De Cobelli O, Saad F, Shariat S, Suardi N, Borghesi M, Terrone C, Karakiewicz P. Sarcomatoid vs. urothelial bladder cancer: Impact of radical cystectomy on cancer control outcomes. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01338-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
49
|
Droghetti M, Bianchi L, Balestrazzi E, Ceci F, Costa F, Pissavini A, Presutti M, Scarlatti R, Farolfi A, Mei R, Castellucci P, Puliatti S, Gandaglia G, Larcher A, Mottrie A, Briganti A, Morganti A, Fanti S, Montorsi F, Schiavina R, Brunocilla E. PSMA-PET for recurrent prostate cancer and guidance of salvage treatments: Is the sooner always the better? (shoot blind or sharpshooting?). Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00312-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
50
|
Pellegrino F, Gandaglia G, Stabile A, Cucchiara V, Mazzone E, Scuderi S, Barletta F, Robesti D, Pellegrino A, Quarta L, Zaurito P, Tenace N, Brembilla G, Lucianò R, De Cobelli F, Montorsi F, Briganti A. Is there a preferential lymph node metastasis pathway in prostate cancer according to the site of the index lesion at multiparametric MRI? A topographic mapping study. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00693-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|